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Summary  
Modulation of glutamatergic transmission by neuropeptides is an essential aspect of neuronal 
network activity. Activation of the hypothalamic somatostatin sst2 receptor subtype by 
octreotide decreases AMPA glutamate responses, indicating a central link between a 
neurohormonal and neuromodulatory peptide and the main hypothalamic fast excitatory 
neurotransmitter. In mediobasal hypothalamic slices, sst2 activation inhibits the AMPA 
component of glutamatergic synaptic responses but is ineffective when AMPA currents are 
pharmacologically isolated. In mediobasal hypothalamic cultures, the decrease of AMPA 
currents induced by octreotide requires a concomitant activation of sst2 receptors with either 
NMDA and/or metabotropic glutamate receptors. This modulation depends on changes in 
intracellular calcium concentration induced by calcium flux through NMDA receptors or 
calcium release from intracellular stores following metabotropic glutamate receptor 
activation. These results highlight an unusual regulatory mechanism in which the 
simultaneous activation of at least three different types of receptors is necessary to allow 
somatostatin-induced modulation of fast synaptic glutamatergic transmission in the 
hypothalamus.   
Since the first demonstration of the depressant action of leucine-enkephalin on glutamate-
evoked responses (Barker et al., 1978), interactions between neuropeptides and amino acids 
have turned out to be a major regulatory mechanism in the control of neuronal excitability and 
neuronal network activity. Neuropeptides affect particularly GABAergic or glutamatergic 
synapses by acting either pre- or postsynaptically. In the case of glutamatergic synapses, 
presynaptic effects lead to a depression or a facilitation of synaptic transmission, as shown 
recently for Neuropeptide Y (McQuiston and Colmers, 1996 ; Bijak, 2000) or Galanin 
(Mazarati et al., 2000), and for Thyrotropin-releasing hormone (Behbehani et al., 1990) or 
oxytocin (Jo et al., 1998) respectively. Neuropeptides also induce postsynaptic changes in 
neuronal electrical properties via activation or inhibition of voltage-dependent currents, thus 
modifying the excitability level of the postsynaptic neurone. However, a direct modulation of 
postsynaptic glutamate sensitivity has been reported in several cases. For example, depression 
of glutamate-induced responses has been observed in the presence of cortistatin (Vasilaki et 
al., 1999) or melanin concentrating hormone (Gao and van den Pol, 2001). Such 
neuropeptide/glutamate interactions are especially relevant in the hypothalamus. In particular, 
amongst many hypothalamic peptides able to efficiently modulate hypothalamic excitatory 
synaptic transmission (Dickson et al., 1993 ; Feleder et al., 1996 ; van den Pol et al., 1996, 
1998 ; Kinney et al., 1998 ; Kombian et al., 2000), somatostatin [somatotropin release 
inhibiting factor, SRIF (Brazeau et al., 1973)] can either increase or decrease glutamate 
sensitivity (Gardette et al., 1995). This dual effect depends on the activation of either sst1 or 
sst2 SRIF receptor subtypes, respectively (Lanneau et al., 1998). However, little is known 
about the intracellular mechanisms implicated in the SRIF control of glutamate sensitivity 
besides the involvement of Gi/Go protein pathways (Boehm and Betz, 1997 ; Lanneau et al., 
1998).  
To better understand the mechanisms involved in the inhibitory effects of SRIF on 
hypothalamic glutamatergic neurotransmission, we focused our attention on sst2 receptor 
subtype and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) glutamate 
receptors (GluRs) in mediobasal hypothalamic (MBH) slices. This hypothalamic area was 
selected because it displays a dense network of somatostatinergic fibres (reviewed in 
Tannenbaum and Epelbaum, 1999) and the localization of the sst2 receptor subtype on MBH 
neurones was thoroughly documented (reviewed in Dournaud et al., 2000). Moreover, 
glutamate is the main excitatory neurotransmitter in this area (van den Pol et al., 1990). In this 
study, we have analysed the effects of the sst2 agonist octreotide (Hoyer et al., 1995) on 1) 
electrically evoked synaptic responses in slices and, 2) on the currents induced by the rapid 
application of glutamatergic agonists in cultured neurones. Activation of sst2 receptor subtype 
decreased AMPA responses in hypothalamic neurones but this occured only with a 
concomitant activation of either N-methyl-D-aspartate (NMDA) or metabotropic (mGluRs) 
glutamate receptors and depended on intracellular calcium concentration.  
 
Methods  
All experimental procedures involving animals and their care were conducted in conformity with INSERM 
committee guidelines and according to the principles expressed in the declaration of Helsinki. 
HYPOTHALAMIC SLICES Experiments were conducted in 1-2 month-old male Sprague-Dawley rats 
(Janvier, Genest St  
Isle, France). Animals were anesthetized with halothane and killed by decapitation using a guillotine. 
The brain was rapidly removed from the skull and placed in a chilled (0-3°C) extracellular solution of 
the following composition (in mM): NaCl, 124; KCl, 3; MgSO4, 1; CaCl2, 2; NaHCO3, 26; NaH2PO4, 
1.25; glucose, 10 (gassed with 95% O2/5% CO2, pH 7.3, 310-320 mOsm). Coronal slices (400 
µm-thick) of the hypothalamus, including the median eminence, were cut using a vibratome 
(Campden Instruments, Leicester, UK). Slices were maintained at 30°C for at least 1 h before 
recording, transferred to a submersion chamber mounted on the stage of an upright microscope (Zeiss 
Axioskop, Iena, Germany) and held with a nylon net. The slice was continuously perfused throughout 
the experiment with gassed (95% O2/5% CO2) extracellular solution at room temperature (20-25°C).  
MEDIOBASAL CELL CULTURES Preparation of MBH cultures was adapted from Lanneau et al. 
(2000b). Sprague-Dawley pregnant rats on the 17th day of gestation were anesthetized with halothane 
and killed by decapitation using a guillotine. A coronal slice was sampled from each fetus and further 
dissected in a ventrocaudal fragment containing MBH. Tissues were pooled and disrupted by 
mechanical trituration in PBS/Fœtal Calf Serum (5%) medium. The cell suspension was spun for 10 
min at 650 g and the pellet resuspensed in a defined serum-free medium. Cells were then seeded on 35 
mm Petri dishes, precoated with gelatin/poly-L-lysine and Fœtal Calf Serum, at a density of 3 MBH 
per dish (650 000 cells per dish). Cells were maintained in a 37°C, 7% CO2 humidified atmosphere, 
and treated from 5 days in vitro on with 1 µM cytosine arabinoside to block glial proliferation. The 
medium was changed twice a week. In such culture conditions, neurones represent more than 85% of 
the cell population.  
ELECTROPHYSIOLOGICAL RECORDINGS In hypothalamic slices, patch clamp recording pipettes 
were made from thick-walled borosilicate glass capillaries (4-6 MΩ when filled with internal solution) 
using a Brown-Flaming horizontal pipette puller (Sutter Instrument Co, Novato, CA). Electrodes were 
filled with an internal solution of the following composition (in mM): KCH3SO4, 140; KCl, 6; MgCl2, 
2; HEPES, 10; EGTA, 1.1; lidocaine N-ethyl bromide (QX-314) 5, ATP-Na2, 4; GTP0Na, 0.5; pH 7.3; 
290-300 mOsm (adjusted with CsOH 0.1M), or for experiments in the presence of 
1,2bis(2-aminophenoxy)ethane-tetraacetic acid (BAPTA) (in mM): KCH3SO4, 120; KCl, 6; MgCl2, 2; 
HEPES, 10; BAPTA, 20; QX-314, 5, ATP-Na2, 4; GTP-Na, 0.5; pH 7.3; 290-300 mOsm. The 
extracellular solution was perfused at 1-2 ml/min. Patch recording pipettes were connected to the 
headstage attached to a three-way piezo-electric micromanipulator (Burleigh, BFI Optilas, Evry, 
France) and neurones were recorded using the whole-cell configuration of the patch-clamp technique 
(Hamill et al., 1981). After the attainment of cell access, transmembrane voltages and currents were 
recorded using an Axopatch 1D amplifier (Axon Instruments, Foster City, CA), digitized using a 
Digidata 1200 interface (Axon Instruments) and stored on a computer. Delivery of command voltages, 
online analysis and storage of current data into data files were driven by the Acquis 1 software (CNRS, 
Paris, France). Neurones were voltage-clamped to –70 mV unless otherwise stated and currents 
recorded at room temperature (20-25°C). Series resistance (10-30 MΩ) was routinely compensated 
(80%). Cell input resistance and membrane capacitance transients were monitored during the entire 
recording by applying a –10 mV voltage step (150 msec) before each stimulation. Cells that exhibited 
changes exceeding 15% during the recording period were rejected. Bipolar tungsten stimulating 
electrodes were placed in the dorsal area of the MBH region to activate synaptic inputs to the recorded 
neurones. In all experiments, stimuli (0.2-1 msec duration, 100-500 µA intensity, 0.06 Hz) were 
applied to construct baseline of postsynaptic responses and to measure the time-dependent effect of 
drugs. Theoritical reversal potentials of mixed Glutamate/GABA, GABA, Glutamate or AMPA 
synaptic responses were calculated using the GHK equation. These values were compared to 
measured mean reversal potentials corrected for junction potentials estimated by measuring the offset 
potential at the end of each recording. In mediobasal cell cultures, neurones were recorded using the 
whole-cell configuration of the patch-clamp technique (Hamill et al., 1981). Borosilicate patch-clamp 
electrodes (4-6 MΩ) were obtained by a two-stage pull on a horizontal electrode puller (BB-CH 
Mecanex, Geneva, Switzerland) and filled with the internal solution of the following composition (in 
mM) : KCH3SO4, 140 ; KCl, 6 ; MgCl2, 2 ; HEPES, 10 ; EGTA, 1.1 ; GTP-Na 0.5 ; ATPNa2, 4; pH 
7.30, 280-300 mOsm or for, the BAPTA experiments, with the following composition (in mM): 
KCH3SO4, 120 ; KCl, 6 ; MgCl2, 2 ;  HEPES, 10 ; EGTA, 1.1 ; BAPTA, 20 ; GTP-Na  
0.5 ; ATPNa2, 4 ; QX-314, 5 ; pH 7.30 ; 280-300 mOsm. QX-314 was omitted from the internal 
medium during the study of mGluRs. The external recording medium, of the following composition 
(in mM) : NaCl, 140 ; KCl, 3 ; CaCl2, 2 ; MgCl2, 2 ; HEPES, 10 ; Glucose, 10 ; tetrodotoxin, 0.5.10
-3 
; 
pH 7.30, 300-320 mOsm, was perfused at 2 ml/min. For the experiment without Ca
2+
 in the external 
medium, the diionic equilibrium of the solution was maintained using BaCl2 2 mM. Patch pipettes 
were mounted in the headstage attached to a three-way piezo-electric micromanipulator (Burleigh, 
BFI Optilas, Evry, France). After the attainment of cell access, transmembrane voltages and currents 
were recorded using an Axopatch 1D (Axon Instruments) amplifier, run on line using an Axon TL-1 
DMA interface and stored on a computer. Delivery of command voltages and storage of current data 
into data files were driven by the Pclamp 6.0.4 software (Axon Instruments). Neurones were 
voltageclamped at –70 mV unless otherwise stated, and currents were recorded at room temperature 
(20-25°C). Series resistance (10-30 MΩ) was routinely compensated (80%). Cell input resistance and 
membrane capacitance transients were monitored as in hypothalamic slices.  
DRUG APPLICATIONS Drug aliquots were dissolved in distilled water or DMSO (< 0.1% final 
concentration in extracellular medium) and kept at –80°C.  
In the hypothalamic slice preparation, drugs aliquots were dissolved in the external medium and 
applied by bath perfusion for at least 10 mn to obtain a steady-state bath concentration.  
The following compounds were used : Bicuculline (Sigma, St Quentin-Fallavier, France) ; D-
2-amino-5-phosphopentanoic acid (AP5, Tocris Cookson Ltd, Bristol, UK) ; 6-cyano-7-
nitroquinoxaline-2 ,3-dione (CNQX; Tocris Cookson) ; 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-
benzo[f]quinoxaline-7-sulfonamide (NBQX, Sigma) ; 1-(4-aminophenyl)-4-methyl-7,8-
methyenedioxy-5H-benzodiazepine hydrochloride (GYKI 52466, Sigma). Octreotide 1 µM (SMS 
201-995, gift from Novartis, Rueil-Malmaison, France) was used as a potent and long acting sst2 
agonist (Hoyer et al., 1995). This compound is also a weak agonist for sst3 and sst5 receptors but sst5 
receptor immunoreactivity has not been detected in the rat MBH (reviewed in Dournaud et al., 2000) 
and sst3 receptors can be excluded from classical pre or postsynaptic sites (reviewed in Schulz et al., 
2000). In mediobasal cell cultures, drug aliquots were diluted in the extracellular medium to the 
desired concentrations. They were applied with a RSC-160 rapid solution changer (Bio-Logic, Claix, 
France). Currents generated by the glutamate receptor agonists L-Glutamate (Sigma), AMPA (Tocris 
Cookson), NMDA (Tocris Cookson) and trans-(+)-1-amino-1.3cyclopentanedicarboxylic acid 
(trans-(+)-ACPD, Tocris Cookson) were measured for a 2 sec application at 0.05 Hz. After acquisition 
of a 10 min baseline current amplitudes, octreotide 200 nM was continuously applied for 10 min. To 
evaluate the effect of the sst2 receptor agonist, a 2 sec application of glutamate agonist(s) plus 
octreotide was delivered every 20 sec. For the study of NMDA responses, D-serine 20 µM was added 
to saturate the strychnineinsensitive glycine site of NMDA receptors (Mothet et al., 2000).   
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF RECORDED NEURONES IN 
HYPOTHALAMIC SLICES In some experiments, biocytin (0.5 mg/ml) was added to the recording 
solution. At the end of  
the recording period, slices were fixed for 2 h in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 
7.4) and cryoprotected at 4° C in 30% buffered sucrose for 24 h. Serial sections (30 µm thick) were cut 
on a freezing microtome, collected in 0.1 M phosphate buffer and immediately processed for double 
labeling studies using either somatostatin or sst2A antibodies and biocytin revelation. For SRIF 
immunohistochemistry, slices were processed using a rabbit polyclonal antiserum directed against 
SRIF [antisomatostatin1-12 (code IS-7), a gift from Dr. G. Tramu, CNRS URA 339, Bordeaux, 
France]. To detect the sst2A receptor, which is the only sst2 isoform expressed in MBH neurones 
(Sarret et al., 1998), a fully characterized antiserum raised in rabbit against the C-terminal segment 
330-369 of the sst2A receptor protein was used (Helboe et al., 1997, 1999 ; Csaba et al., 2001, 2002). 
Free-floating sections were incubated overnight at room temperature in 1:4000 anti-SRIF antibody or 
in  
1:400 anti-sst2A antibody. SRIF and sst2A antibodies were diluted in 0.1M Tris buffer Saline pH 7.4 
(TBS), containing 0.3% Triton X-100 and either 0.5% normal goat serum (NGS) or 0.5% normal 
donkey serum (NDS). SRIF antibodies were revealed by incubating sections for 45 min in 1:500 goat 
Cy3-conjugated anti-rabbit IgG (red fluorescent signal ; Jackson Immunoresearch, West Grove, PA) 
diluted in TBS containing 5% NGS and 0.3% Triton X 
100. Sst2A receptor antibodies were revealed using 1:4000 donkey Cy3-conjugated antirabbit IgG 
(red fluorescent signal ; Jackson Immunoresearch, West Grove, PA) diluted in TBS containing 5% 
NDS and 0.3% Triton X-100. After several washes, sections were incubated for 45 min in 1:4000 
Streptavidin FITC (green fluorescent signal ; Jackson Immunoresearch, West Grove, PA) diluted in 
TBS to reveal biocytin injected through the recording pipette. Sections were then rinsed in TBS, 
mounted on glass slides and coverslipped with a Vectashield solution (Vector Laboratories). Sections 
were analyzed by Confocal Laser Scanning Microscopy using a TCS SP2 confocal imaging system 
equipped with Ar 488 nm and HeNe 543 nm lasers (Leica Microsystems, Heidelberg, Germany). 
Digital images were collected from a single optical plane using a 40x Plan-Apochromat oil-immersion 
lens (NA 1.25). Pinhole setting was 0.75 Airy unit (AU) for all images. For each optical section, 
double fluorescence images were acquired in sequential mode to avoid potential contamination by 
linkage specific fluorescence emission "cross talk".  
SINGLE CELL MULTIPLEX RT-PCR OF SST mRNAs  
Cells were first patched and cytoplasm harvested by applying a gentle negative pressure to the 
pipette. The tip of the pipette was then broken in a PCR sterile tube and submitted to retrotranscription 
for 1h at 37°C as already described (Lanneau et al., 2000b). The resulting 15µl sample was kept at –
80°C. Coamplification of the cDNAs encoding the five sst1-5 somatostatinergic receptors was 
performed simultaneously. Primers were identical to primers used in a previous study (Table I in 
Lanneau et al., 2000b).  
RT reaction products were first amplified in the presence of every primer (25 pmol each) in a 100 
µl volume in an automatic thermocycler (Genius Techne, Cambridge, UK) during 20 cycles (94°C for 
30 sec, 56°C for 30 sec, 72°C for 30 sec). An extension step was then performed at 72°C for 10 min. 
PCR products were purified from primers and salt using Nucleon QC microspin (Amersham, 
Rainham, UK).   
A second round of PCR was then performed using 2 µl of the first purified PCR products as 
template. In this round, each marker was amplified individually using its specific primer pair for 28-35 
cycles. All markers were amplified as described for the first amplification step. Amplification was 
performed in an automatic thermocycler (Hybaid, Teddington, UK) (94°C for 30 sec, 58-60°C for 30 
sec, 72°C for 30 sec).  
Fifteen microliters of each individual PCR reaction were then run on 2% agarose gel stained with 
Gel Star (FMC Bioproducts, Rockland, ME). In each experiment, cytoplasms with nucleus were 
submitted to the entire protocol without reverse transcriptase. The intronic sequence of SRIF amplicon 
was never detected, thus ruling out genomic DNA contamination.  
DATA ANALYSIS For each cell, amplitudes of evoked or induced currents were normalized relative to 
responses prior to drug application. Octreotide effect was estimated from amplitude mean decrease  
under drug in slices and from maximal mean decrease of steady-state currents in cultures. Statistical 
significance of amplitude variation within each cell was determined using a Student’s t test and 
Bonferonni correction for small samples. Differences were considered significant if p<0.05. This 
procedure allowed recorded neurones to be classified in two different populations: 
octreotide-sensitive and octreotide-insensitive. Mean amplitudes of octreotide effect were then 
compared using ANOVA. Data are expressed as mean ± s.e.m.  
 
Results  
SYNAPTIC STIMULATIONS IN HYPOTHALAMIC SLICES Synaptic currents in response to electrical 
stimulation were recorded in 55 neurones in order  
to characterize mixed glutamate and γ-aminobutyric acid (GABA) responses (n=12, no antagonist), 
pure GABA (n=11, addition of CNQX and AP5), glutamate (n=14, addition of bicuculline), AMPA 
(n=6, addition of bicuculline and AP5) or NMDA (n=6, addition of bicuculline and CNQX) responses, 
and glutamate responses in presence of intracellular BAPTA (n=6, addition of bicuculline). NBQX 
(1µM) and GYKI 52466 (20µM) were applied in order to block AMPA receptors and reveal kainate 
currents (Kawai and Sterling, 1999 ;  
Chergui et al., 2000). In such conditions, complete blockade of the synaptic response was observed, 
even after high stimulation intensities or frequencies (Vignes and Collingridge, 1997), thereby ruling 
out the presence of a kainate synaptic component. Current voltage (I-V) curves were also obtained 
from 20 neurones in order to characterize the I-V relationship for each type of synaptic response. The 
observed reversal potentials were : -17 + 4 mV for mixed glutamate/GABA responses (Fig 1A, n=4), 
-52 + 2 mV for pure GABA responses (Fig 1B, n=8), +13 + 5 mV for pure glutamate responses (Fig 
1C, n=5), and  12 + 6 mV for AMPA responses (Fig 1D, n=3), in agreement with calculated GHK 
reversal potentials in our experimental conditions (GABA : -50 mV, glutamate : +13 mV, AMPA : 
+13 mV). As shown in Figure 2A and 2B, mixed glutamate/GABA synaptic responses were decreased 
by –28.8 + 3.8 % under octreotide (p<0.001 vs control values before octreotide in responsive cells, 
n=5, and values under octreotide in non responsive cells, n=7). The octreotide effect took place about 
three minutes after the beginning of the perfusion and slowly increased during its application. No 
recovery was observed. To test whether octreotide affected specifically glutamate and/or GABA 
components of the synaptic responses, experiments were reproduced in the presence of either CNQX 
and AP5 (n=11) to isolate the GABA component, or bicuculline (n=14) to isolate the glutamate 
response. Octreotide had no effect on the GABA component (Fig 2C,D) whereas octreotide inhibited 
the glutamate component in 43% of the recorded neurones (6/14, fig 2E,F) with an average decrease of 
–32.3 + 5.9 % (p<0.001 vs control values before octreotide in responsive cells, n=6, and values under 
octreotide in non responsive cells, n=8). The amplitude and kinetics of octreotide effects on glutamate 
responses were not significantly different from those observed for mixed glutamate/GABA responses. 
NMDA contribution to total glutamate current was estimated by applying AP5 and represented around 
5% of the total synaptic current at a holding potential of –70 mV and in the presence of Mg
2+
 (1 mM) in the 
perfusion solution (data not shown). These results suggest that the sst2 agonist modulates mainly the AMPA component of the glutamate synaptic 
response. However, when the AMPA component was isolated by addition of both bicuculline and AP5, octreotide was ineffective at inhibiting the 
response in 6 out of 6 recorded neurones (fig 2G,H).  
This led us to test whether an influx of calcium through NMDA channels might be required to observe 
octreotide effects. Indeed, octreotide modulation of glutamate synaptic responses was abolished by 
intracellular injection of BAPTA in every tested neurone (n=6, Fig 2I,J). To rule out a presynaptic 
inhibition of glutamate release related to calcium-induced release of a retrograde messenger from the 
postsynaptic cell, the effect of octreotide was tested on pharmacologically isolated NMDA synaptic 
currents (n=6). Holding potential was set to –20 mV to remove Mg
2+
 blockade and allow a larger 
calcium influx. Under these conditions, no effect of octreotide was ever observed (data not shown).  
As shown in Figure 3, recorded MBH neurones were surrounded by a dense network of 
somatostatinergic fibers in close apposition to neuronal perykarya and dendrites.   
Regional examination of slices immunoreacted with the sst2A receptor antibody revealed that 
numerous immunopositive neurones were apparent throughout the MBH (data not shown).  In 
accordance with previous studies (reviewed in Dournaud et al., 2000), the largest proportion of 
receptor-expressing cells was observed in the arcuate nucleus. At the cellular level, receptor 
immunolabeling was confined to small spherical granules displaying the morphological features of 
endosomes distributed at the periphery of the cells as well as within intracellular compartments. Such 
cellular distribution has been recently described in other brain regions and reflect activation and 
subsequent internalization of cell-surface sst2A receptors in response to agonist stimulation (Csaba et 
al., 2001, 2002). Combined electrophysiological recordings with double-labeling experiments 
revealed  that biocytinfilled neurones displaying no octreotide-induced changes in glutamate synaptic 
currents never expressed sst2A receptor immunolabeling (Fig 4A-C) while responsive cells displayed 
sst2A receptor immunoreactivity (Fig 4D-F).  
FAST APPLICATIONS OF AGONISTS IN MEDIOBASAL CELL CULTURES  
The lack of effect of octreotide on the AMPA component of the synaptic response on the one hand, and 
the BAPTA blockade of octreotide-induced decrease of the glutamate synaptic response on the other 
hand, led us to determine whether a coactivation of non-NMDA and NMDA glutamate ionotropic 
receptor subtypes was necessary to observe the sst2 modulation of the AMPA responses. Indeed, the 
linearity of synaptic glutamate and AMPA I-V curves (see additional material) strongly suggested that 
the activated glutamate receptors contained the edited GluR2 subunit and were not permeable to 
calcium (Jonas et al., 1994).  Experiments were performed on a total number of 78 isolated neurones 
in primary cultures allowing fast perfusion of the cells with octreotide and various glutamate agonists 
alone or in combination. In cells held to –70 mV and in the presence of 2 mM Mg
2+
, the AMPA current 
represented more than 95% of the total recorded inward current, thus indicating a 5% contribution of 
NMDA activation, similar to that recorded for synaptic responses in slices. As previously reported, at 
the agonist concentrations used herein, AMPA-mediated responses displayed no fast peak current 
(Swandulla et al., 1994). As shown in Figure 5A and 5B, the fast application of octreotide + glutamate 
decreased the glutamate-induced inward current in 43% of the tested neurones (3/7) with a maximum 
average decrease of –15.9 + 4.1 % (p<0.001 vs control values before octreotide in responsive cells, 
n=3, and values under octreotide in non responsive cells, n=4). As opposed to slice experiments, 
octreotide effect desensitized rapidly before the end of application. Octreotide-induced decrease was 
also found when all glutamate receptor subtypes were activated by coapplying AMPA, NMDA and 
trans(+)-ACPD in 38% of the tested cells (3/8) with a comparable maximum average decrease of –12.5 
+ 0.4 % (p<0.001 vs control values before octreotide in responsive cells, n=3, and values under 
octreotide in non responsive cells, n=5 ; Fig 5C,D). Fast application of AMPA with octreotide on 9 
cells never led to a decreased AMPA current (Fig 5E,F) while octreotide coapplied with AMPA and 
NMDA decreased the AMPA current by –8.4 + 1.6 % (p<0.001 vs control values before octreotide in 
responsive cells, n=5, and values under octreotide in non responsive cells, n=8, Fig 5G,H). In a second 
series of experiments, we tested whether calcium influx through the coactivated NMDA receptors 
could be responsible for restoring octreotide modulation of the AMPA current. As shown in Figure 5I 
and 5J, omitting calcium from the extracellular medium totally abolished the decrease of AMPA 
current during coapplication of AMPA, NMDA and octreotide in all 15 tested neurones. However, 
octreotide was still able to decrease glutamate response by –14.1 + 1.7 % in 3 out of 7 tested cells even 
in the absence of extracellular calcium (data not shown) suggesting that mGluRs were involved in 
sst2/AMPA receptor interactions.  
ROLE OF METABOTROPIC GLUTAMATE RECEPTORS Experiments were performed in cultured 
neurones with no extracellular calcium. Agonist coapplications with octreotide included AMPA and 
trans-(+)-ACPD in order to activate GluRs and mGluRs, respectively. Under these conditions, 
octreotide was effective in reducing AMPA current in 43% of the recorded neurones (3/7, Fig 6A,B) 
with a maximal effect of –  
15.1 + 3.5 % which desensitized rapidly. After intracellular perfusion of BAPTA, 3 out of 6 tested 
cells were still responsive to octreotide (Fig 6C,D), but the magnitude of the effect was significantly 
diminished (–7.8 + 1.0 % vs –15.1 + 3.5 % in the absence of BAPTA, p<0.001). Furthermore, a 45 
minute preincubation with thapsigargin, to deplete intracellular calcium stores, totally abolished the 
effect of octreotide on AMPA currents elicited during a coapplication of AMPA and trans-(+)-ACPD 
(Fig 6E,F, n=6).  
DISTRIBUTION OF SST mRNAs IN  MBH CELL CULTURES Cytoplasms were harvested from 39 
neurones from rat MBH cell cultures and were processed in order to detect expression of the five sst 
mRNAs at the single cell level. 31% (12/39) of the  
neurones expressed no sst mRNAs. A same proportion of the cells (12/39) expressed only one subtype 
whereas the simultaneous expression of 2, 3, 4 or 5 subtypes was detected respectively in 26% (10/39), 
8% (3/39), 5% (2/39) and 0% (0/39) of the neurones. The mRNA signal for the sst2 subtype was found 
in 49% of the neurones, in close agreement with the proportion of octreotide-sensitive cells. The 
distribution of the other mRNAs subtypes was as follows : sst4 (36%) > sst1 (28%) > sst5 (8%) > sst3 
(5%).  
 
Discussion  
In this study, we first determined the role of the sst2 receptor subtype on synaptic transmission in rat 
MBH slices. Electrical stimulation of the dorsal part of MBH elicited mixed glutamatergic and 
GABAergic synaptic responses in all recorded neurones, in keeping with the major role attributed to 
these two amino acids in the hypothalamic network (van den Pol et al., 1990 ; Decavel and van den Pol, 
1990). Sst2 modulation of the GABA component was never observed, suggesting that 
octreotide-induced decrease of mixed synaptic responses was entirely due to the effect of the peptide 
on the glutamate component. Such a lack of SRIF effect on GABAergic transmission has previously 
been reported in the hippocampus (Boehm and Betz, 1997 ; Tallent and Siggins, 1997). Glutamate 
responses were decreased by octreotide in  43% of the recorded neurones and octreotide sensitivity 
was correlated to the presence of sst2A receptor immunoreactivity. This proportion of octreotide 
sensitive neurons in MBH slices is in close agreement with the proportion of sst2 receptor-expressing 
neurones observed in culture by single cell RT-PCR in this study (49%) as well as in previous reports 
on mouse hypothalamic neurones (40%, Lanneau et al., 1998 ; 44%, Lanneau et al., 2000a). Octreotide 
modulation appeared mainly targeted to the AMPA component which represents the main component 
of fast excitatory transmission within the hypothalamus (Wuarin and Dudek, 1993).   
The effect of octreotide appears unrelated to a depression of neurotransmitter release from presynaptic 
terminals (Boehm and Betz, 1997) since neither the postsynaptic NMDA component of the synaptic 
response nor GABA synaptic responses were affected by the peptide. A decrease in postsynaptic 
neuronal excitability, mediated by sst2-modulation of postsynaptic voltage-dependent ionic channels 
(reviewed in Patel, 1999), is also unlikely because such a decrease would have equally affected the 
amplitude of AMPA or GABA responses. Sst2-induced inhibition totally disappeared when the 
AMPA component was pharmacologically isolated. This indicates that, in such experimental 
conditions, one essential element  between the sst2 receptors and the GluRs was missing. The main 
difference between non-selective glutamate-and selective AMPA-receptor mediated responses was the 
pharmacological blockade of NMDA receptors in the latter protocol. Indeed, octreotide inhibition of 
AMPA responses was restored in cultured neurones when NMDA was coapplied with AMPA.. Based 
on previously published reports demonstrating the expression of GluR2 mRNA in mediobasal 
hypothalamic areas (van den Pol et al., 1994; Eyigor et al., 2001) and given the linearity of AMPA I-V 
curves observed in both slices and isolated neurones, it appears most likely that native AMPA 
receptors expressed by hypothalamic neurones contained the edited GluR2 subunit and thus display no 
calcium permeability (Burnashev et al., 1992; Jonas et al., 1994). Thus calcium fluxes through NMDA 
receptors may be necessary for the expression of the sst2-induced modulation of AMPA currents. In 
the slice experiments, involvement of mGluRs-induced calcium release from intracellular stores 
appeared unlikely since 1) these receptors are located at a distance from the synaptic zone and 2) they 
require higher frequencies of stimulation to be activated (Ottersen and Landsend, 1997).   
The role of intracellular calcium in the sst2-induced modulation of AMPA current is supported by 
several arguments. When calcium was omitted from the extracellular medium in cultures, the effect of 
octreotide was abolished. When intracellular calcium was chelated by BAPTA, sst2-induced inhibition 
of glutamate synaptic responses was blocked. Moreover, in cultures, octreotide effect was restored by 
the coactivation of GluRs and mGluRs, strongly depressed by intracellular BAPTA and abolished by 
thapsigargin preincubation. This last observation suggested that calcium ions involved in the 
sst2-AMPA modulation pathway may arise indifferently from extracellular or intracellular sources. 
The fact that octreotide-induced inhibition of AMPA currents was restored even when coactivated 
NMDA currents represented, in our experimental conditions, only about 5% of total 
glutamate-mediated currents is rather surprising. Indeed, the calcium influx mediated by such a small 
amount of current is probably not very consequent. One hypothesis could be that calcium transients 
elicited by NMDA receptor activation are confined to a space near the site of entry (Yuste and Denk, 
1995) leading to a very local rise in calcium-concentration sufficient to trigger intracellular events in a 
microdomain containing the different receptor subtypes. In keeping with this hypothesis, it has been 
recently shown that calcium transients restricted to the the immediate vicinity of the site of calcium 
entry represents the on switch for ERK1/2 kinase signaling independently of global increases in 
calcium concentration (Hardingham et al., 2001). Alternatively, this local calcium increase could be 
responsible for the onset of a calcium-induced calcium release mechanism, as shown in hippocampal 
dendritic spines (Emptage et al., 1999), leading to substantial calcium release from the internal stores 
close to glutamate and sst2 receptors and subsequent activation of intracellular messengers. Octreotide 
induced an equivalent decrease of AMPA currents when mGluRs alone, or mGluRs + NMDA 
receptors together, are activated. This suggests that a mGluRs-induced increase in intracellular 
calcium alone can lead to a maximal effect of octreotide on AMPA transmission. Such a result may be 
highly relevant in the functioning of synaptic networks, especially in view of the putative corelease of 
glutamate  and somatostatin (Lanneau et al., 2000b). During synaptic transmission with a low rate of 
action potential firing, AMPA and NMDA receptors are activated and only a modest release of 
neuropeptides occurs (Hökfelt, 1991). In this case, decrease of excitatory synaptic transmission by sst2 
activation would be very low, due to a low level of activation of sst2 receptors by basal somatostatin 
release. An increase in the rate of action potential discharge, such as in kindling or status epilepticus, 
will lead to an enhanced release of both somatostatin (Manfridi et al., 1991 ; Vezzani et al., 1992) and 
glutamate from nerve terminals. In such conditions, the simultaneous activation of sst2 and mGluRs 
will result in a higher inhibition of excitatory transmission. Thus, activation of sst2 receptors may 
represent a physiological brake against overexcitation of synaptic networks. This hypothesis may be 
relevant to further define the mechanisms of the inhibitory role of somatostatin in seizures and 
epileptogenesis (Vezzani and Hoyer, 1999). We observed, in slices, a mean octrotide-induced 
depression of glutamate responses that was twice that observed in cultures neurones (32% versus 
16%). This difference may be related to a release of maximal concentrations of glutamate when using 
evoked potentials in the slice, leading to maximal AMPA responses, whereas the low agonist 
concentration used in cultured neurones would activate only a subset of available AMPA receptors and 
induce a smaller excitatory current. This may lead to a less efficient effect of the sst2 agonist on the 
smaller glutamate responses. Alternatively, glutamate receptors activated during the fast application or 
the electrical-induced synaptic responses are differentially located on the postsynaptic cell. Thus, only 
synaptically-based receptors would respond to a single-shock electrical stimulation whereas both 
synaptically and extrasynaptically-located receptors would be activated when applying drugs. Such a 
differential receptor distribution at the neuronal surface leads to different regulation of receptor 
subtypes (Morishita et al, 2001). Thus, sst2 activation may lead to a larger octreotide-induced 
depression of synaptically-based receptors than of extrasynaptically-based ones, reflected by a more 
potent effect of the sst2 agonist in slices than in cultures. The octreotide response desensitized rapidly 
in cultures as opposed to slices. Such a discrepancy between the slice and dispersed neurone protocols 
has previously been observed. For instance, inhibition of ICa by somatostatin in cultured chick 
sympathetic neurones desensitizes with a time for half desensitization of approximately 3 minutes 
(Golard et al., 1993), as observed in the present experiments in cultured hypothalamic neurones. On 
the opposite, Tallent and Siggins (1997) reported that somatostatin-induced depression of 
AMPA/kainate EPSCs in rat hippocampal slices did not desensitize in their recording conditions. 
Since somatostatin receptor desensitization was hypothetized to be dependent on receptor 
internalization rather than on phosphorylation events (Beaumont et al., 1998), the differences observed 
in desensitization kinetics between cultures and slices may be related to different internalization 
processes. Indeed, it has been shown in different culture systems that the maximal rate of rat sst2 
internalization ranged between 50% and 95% (reviewed in Csaba and Dournaud, 2001) whereas it 
reaches only 20-30% in rat brain slices even after a 40 minute exposure to sst2 agonist (Boudin et al, 
2000). Therefore, it is likely that the available number of membrane sst2 receptors is largely decreased 
in isolated cultured cells as compared to slices. This may explain the persistance of octreotide effect in 
slices as opposed to its rapid disappearance in isolated hypothalamic neurones.  Previously reported 
effects of SRIF on neurotransmitter-activated receptors dealt with SRIFinduced changes of 
postsynaptic sensitivity and only involved two classes of postsynaptic receptors (reviewed in Vezzani 
and Hoyer, 1999). To our knowledge, only one example showed a true cooperativity between receptors 
: in SH-SY5Y human neuroblastoma cells, SRIF applied alone is ineffective on intracellular calcium 
levels whereas coapplication of SRIF and carbachol evoked an elevation above that caused by 
carbachol alone (Connor et al., 1997). However, cooperativity between several transmitters has 
already been shown, such as for serotonin, adenosine and SRIF in the coupling of their respective 
receptors to an inwardly rectifying potassium current (Sodickson and Bean, 1998). Such observations 
are in keeping with the present results where coactivation of three receptors is required to produce a 
biological effect (Figure 7).  A link between intracellular calcium and the different ionotropic 
glutamate receptor subtypes has recently been evidenced, such as the control of the targeting of 
GluR2-containing GluRs by Ca2+-permeable GluRs (Liu and Cull-Candy, 2000), or a transient 
depression of the kainate receptor current induced by Ca
2+
 influx through NRs (Ghetti and Heinemann, 
2000). Interactions between receptors belonging to different families such as ionotropic and G 
protein-coupled receptors also exist. Thus, a rise of postsynaptic calcium is required for the induction 
of D1/D5-induced sustained enhancement of GluRs- and NRs-mediated currents (Yang, 2000). Given 
the broad spectrum of the intracellular targets modified by the increase in calcium ions, several 
hypotheses can be considered in the interaction between sst2 and glutamate receptors depending on 
intracellular calcium. Common intracellular targets to both intracellular calcium (reviewed in 
Berridge, 1998) and sst2 (reviewed in Csaba and Dournaud, 2001) mostly involve kinases or 
phosphatases such as the adenylate cyclase/cAMP/PKA (reviewed in Schindler et al., 1996) or the 
MAP kinase (reviewed in Cole and Schindler, 2000) pathways. An interaction between calcineurin 
phosphatase and sst receptors activated by SRIF-28 has also been described (Zhu and Yakel, 1997). 
Activation of these pathways in response to both sst2 and intracellular calcium may lead to 
phosphorylation or dephosphorylation of GluRs (reviewed in Greengard, 2001), a major mechanism in 
the regulation of neurotransmitter receptors (reviewed in Swope et al., 1992). For example, 
dephosphorylation of GluRs is observed during long term depression in the hippocampus, a 
phenomenon associated with a decrease in GluRs sensitivity (Lee et al., 1998). Interestingly, this 
NMDA-induced long term depression associated with dephosphorylation of GluRs can be observed 
after only a 3 minute application of NMDA, a delay compatible with our present observations (Lee et 
al., 1998).  Alternatively, the sst2 receptor itself could be the target for phosphorylation or 
dephosphorylation following intracellular calcium rise (reviewed in Csaba and Dournaud, 2001), a 
mechanism that could account for changes in sst2 receptor properties allowing AMPA modulation. 
Finally, a direct interaction between sst2 receptor and GluRs, induced by intracellular calcium rise, 
could also account for the modifications of glutamate responses. Such a physical association has 
recently been demonstrated between dopamine D5 receptor subtype, a G protein-coupled receptor as 
the sst2 receptor, and GABAA receptor subtype, a ligand-gated channel mediating fast interneuronal 
synaptic transmission analogous to GluRs (Liu et al., 2000). It has been demonstrated that sst2 can 
physically bind to proteins with anchoring and scaffolding functions (Zitzer et al., 1999). One of these 
proteins, named SSTRIP (sst receptor interacting protein, or SHANK1), also binds, directly or by other 
binding proteins, to NRs, mGluRs and GluRs (reviewed in Craig and Boudin, 2001). Therefore, this 
physical link may, under calcium control, modify AMPA sensitivity by a mechanism comparable to 
that of Homer proteins controlling constitutive activity of mGluR1a or mGluR5 receptors (Ango et al., 
2001). In summary, the modulation of GluRs sensitivity by activation of the SRIF sst2 receptor 
subtype represents a complex mechanism under the control of intracellular calcium levels. The 
calcium rise is induced by Ca
2+
 influx through NMDA receptors and/or by calcium release from 
internal stores after mGluRs activation. These two pathways are most likely implicated in the 
modulation of glutamate sensitivity in different physiological conditions, either during normal 
synaptic transmission for NMDA receptors or in the case of excitatory hyperactivity for mGluRs. 
These results suggest an unsuspected regulatory mechanism involving at least three different receptor 
subtypes and bring a new level of interaction in the modulatory effects of neuropeptides on fast 
synaptic transmission.  
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Figure 1 : Electrophysiological and pharmacological characterization of evoked synaptic 
responses in mediobasal hypothalamic slices.  
 (A) Current-voltage plot of synaptic responses. Membrane potential was clamped at –70 mV 
to +10 mV, at 10 mV steps. The reversal potential was –17 + 4 mV (n=4). Synaptic responses  
 (1) were partially blocked by bath application of ionotropic glutamate receptor antagonists 
CNQX 10µM and AP5 50µM (2). CNQX and AP5-resistant response was totally blocked by addition 
of the GABAA antagonist bicuculline 10µM (3).  
 (B) Current-voltage plot of GABAergic synaptic responses recorded in the presence of 
CNQX 10µM and AP5 50µM. Membrane potential was clamped at –70 mV to -30 mV, at 10 mV 
steps. The reversal potential was –52 + 2 mV (n=8). The synaptic response (1) was totally blocked by 
bath application of bicuculline 10µM (2).  
 (C) Current-voltage plot of glutamatergic synaptic responses recorded in the presence of 
bicuculline 10µM. Membrane potential was clamped at -70 mV to +30 mV, at 10 mV steps. The 
reversal potential was 13 + 5 mV (n=5). Synaptic responses (1) were totally blocked by bath 
application of CNQX 10µM and AP5 50µM (2).  
 (D) Current-voltage plot of AMPA synaptic responses recorded in the presence of bicuculline 
10µM and AP5 50µM. Membrane potential was clamped at -70 mV to +30 mV, at 10 mV steps. The 
reversal potential was 12 + 5 mV (n=3). Synaptic responses (1) were totally blocked by bath 
application of NBQX 1µM and GYKI 52466 20µM (2). Each trace in insets was obtained by 
averaging 3 responses. Scale bars 50 pA, 20 ms Figure 2 : Effect of the sst2 receptor agonist 
octreotide on the amplitude of evoked synaptic responses in mediobasal hypothalamic slices.  
 (A) Time plot of normalized evoked synaptic responses. Five neurones displayed a highly 
significant decreased synaptic response during octreotide application () and 7 neurones were 
unresponsive (■).  
 (B) Average recording of 3 synaptic current traces before (CTRL) and during octreotide 
application (OCT) in one responsive neurone.  
 (C) Time plot of normalized evoked GABAergic synaptic responses. Synaptic responses 
were unaffected by octreotide in 11 tested neurone (■).  
 (D) Average recording of 3 GABAergic synaptic current traces in one neurone before 
(CTRL) and during octreotide application (OCT).  
 (E) Time plot of normalized evoked glutamatergic synaptic responses. Synaptic responses 
were highly significantly depressed under octreotide application in 6 neurones () and unaffected in 8 
neurones (■).  
 (F) Average recording of 3 glutamatergic synaptic current traces before (CTRL) and during 
octreotide application (OCT) in one responsive neurone.  
 (G) Time plot of normalized evoked AMPA synaptic responses. None of the 6 tested 
neurones showed a depressed synaptic response during octreotide application (■).  
 (H) Average recording of 3 AMPA synaptic current traces in one neurone before (CTRL) and 
during octreotide application (OCT).  
 (I) Time plot of normalized evoked glutamatergic synaptic responses in the presence of the 
calcium chelator BAPTA in the recording pipette. None of the 6 tested neurones showed depression 
of synaptic responses during octreotide application  (■).  
 (J) Average recordings of 3 glutamatergic synaptic current traces in one neurone before 
(CTRL) and during octreotide application (OCT) in the presence of intracellular BAPTA. Scale bars : 
50 pA, 10 ms  
 Figure 3 : Dense somatostatinergic innervation of recorded mediobasal hypothalamus 
neurones.  
 (a) The recording area (*, bleaching due to image acquisition) is included in a dense network 
of somatostatinergic fibres. (b) Biocytin revelation by FITC-labelled streptavidin of a recorded cell. 
(c) Somatostatinergic fibres in the vicinity of the recorded neurone. (d) Merged images of b and c 
illustrates the dense network of somatostatinergic fibres surrounding the recorded neurone. (e) single 
focal acquisition showing the presence of close appositions between somatostatinergic fibres and the 
neuronal perikaryon or dendrites (arrows). Scale bars : 200 µm in a, 10 µm in b (applies to b,c,d) and 
e ; ARC, arcuate nucleus ; ME, median eminence ; VMH, ventromedial hypothalamic nucleus ; 3V, 
third ventricle.  
 
Figure 4 : Correlation between octreotide sensitivity and sst2A receptor expression (A-D) A : 
Average recording of 3 glutamatergic synaptic current traces before (CTRL) and during octreotide 
application (OCT) in one biocytin-injected unresponsive MBH neurone. Revelation of both biocytin 
(B) and sst2A receptor immunoreactivity (C) show the absence of sst2A receptor expression by the 
recorded neurone (D). (E-H) E : Average recording of 3 glutamatergic synaptic current traces before 
(CTRL) and during octreotide application (OCT) in one biocytin -injected responsive MBH neurone. 
Double labeling experiments indicate that the recorded neurone (F) displayed sst2A receptor 
immunoreactivity (G,H). Scale bars : a : 50 pA, 20 ms ; e : 40 pA, 5 ms ; d, h : 4 µm(applies to b-d and 
f-g).  
Figure 5 : Effect of the sst2 receptor agonist octreotide on the activation of glutamate 
receptors in mediobasal hypothalamic cultures.  
 (A) Time plot of normalized glutamate-induced responses. 3 neurones presented a highly 
significant depression of the response during octreotide application () and 4 neurones were 
unresponsive (■).  
 (B) Recordings of glutamate-induced currents before (CTRL) and during octreotide 
application (OCT) in one responsive neurone.  
 (C) Time plot of normalized responses to coapplication of AMPA, NMDA and trans(+)-
ACPD. Three neurones showed a highly significant depression of the responses during octreotide 
application () and five neurones were unaffected (■).  
 (D) Recordings of AMPA/NMDA/trans(+)-ACPD currents before (CTRL) and during 
octreotide application (OCT) in one responsive neurone.  
 (E) Time plot of normalized AMPA-induced responses. No change in the response was 
observed under octreotide in 9 tested neurones (■).  
 (F) Recordings of AMPA-induced currents in one neurone before (CTRL) and during 
octreotide application (OCT).  
 (G) Time plot of normalized responses to coapplication of AMPA and NMDA. Five neurones 
showed a highly significant depression of the responses during octreotide application () and 8 
neurones were unaffected (■).  
 (H) Recordings of AMPA/NMDA currents before (CTRL) and during octreotide application 
(OCT) in one responsive neurone.  
 (I) Time plot of normalized responses to coapplication of AMPA and NMDA in the absence 
of external calcium. No depression of AMPA/NMDA responses was observed in the presence of 
octreotide in any of 15 tested neurones (■).  
 (J) Recordings of AMPA/NMDA currents in one neurone before (CTRL) and during  
octreotide application (OCT) in the absence of external calcium. 
Each trace was fitted by a spline curve with a uniform local average smoother of span 100.  
 
 Scale bars : 20 pA, 1 s  
Figure 6 : Role of group I mGluRs in sst2-evoked AMPA depression in mediobasal 
hypothalamic cultures.  
(All experiments were performed in the absence of extracellular calcium) 
 
 (A) Time plot of normalized responses to coapplication of AMPA and trans-(+)-ACPD. 3 
neurones displayed a highly significantly decreased response during octreotide application () and 4 
neurones were unresponsive (■).  
 (B) Recordings of AMPA/trans-(+)-ACPD currents before (CTRL) and during octreotide 
application (OCT) in one responsive neurone.  
 (C) Time plot of normalized responses to coapplication of AMPA and trans-(+)-ACPD with 
BAPTA in the recording pipette. The inhibitory effect of octreotide was highly significantly 
decreased in 3 neurones () as compared to its effect in the absence of BAPTA (a).  
 (D) Recordings of AMPA/trans-(+)-ACPD currents in the presence of BAPTA before 
(CTRL) and during octreotide application (OCT) in one responsive neurone.  
 (E) Time plot of normalized responses to coapplication of AMPA and trans-(+)-ACPD 
following a thapsigargin pretreatment. No inhibitory effect of octreotide could be detected in 6 tested 
neurones (■).  
 (F) Recordings of AMPA/trans-(+)-ACPD currents in one neurone after thapsigargin 
pretreatment before (CTRL) and during octreotide application (OCT). 
Each trace was fitted by a spline curve with a uniform local average smoother of span 100.  
Scale bars : 20 pA, 1 s  
Figure 7 : Schematic representation of sst2/AMPA interactions through intracellular calcium 
modifications. 
During synaptic transmission, release of glutamate (Glu) from nerve endings activate AMPA 
(GluRs) and NMDA (NMDARs) receptors, as well as, when synaptic activity increases, 
 
 metabotropic glutamate receptors (mGluRs). The activation of NMDA receptors and/or 
mGluRs induces an increase in intracellular calcium concentration (Ca
2+
). Calcium  sources can be 
either extracellular, ions flowing through NMDA receptors, or intracellular, ions being released from 
endoplasmic reticulum (ER) following activation of the inositol phosphate pathway (IP) by mGluRs. 
Simultaneously, somatostatin (SRIF), released from identical or different nerve terminals, activates 
sst2 receptors (sst2). The activation of Gi/Go protein coupled-sst2 receptors induces a decrease in the 
amplitude of glutamate-induced AMPA currents. If intracellular calcium concentration does not 
increase, sst2-modulation of GluRs does not occur. Thus, the amplitude of the sst2-induced inhibitory 
modulation depends on intracellular calcium levels. Putative links between calcium, sst2 and GluRs, 
are shown in the inset.  
 (P) = phosphorylation/dephosphorylation sites.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
